Utama › Kanser Metastatik › Louisiana › Baton Rouge
Kajian klinikal Kanser Metastatik di Baton Rouge, LA
9 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Baton Rouge (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Mengambil pesertaFasa 3
- Research Site, Baton Rouge
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Mengambil pesertaFasa 3
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Our Lady of the Lake RMC, Baton Rouge
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Mengambil pesertaFasa 1/2
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Mary Bird Perkins Cancer Center, Baton Rouge
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Our Lady of the Lake, Baton Rouge
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Mengambil pesertaFasa 3
- Mary Bird Perkins Cancer Center, Baton Rouge
Kajian Kanser Metastatik di bandar lain
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Washington, DC43 kajian
- Dallas, TX42 kajian
Kajian lain di Baton Rouge
- Obesiti15 kajian
- Berat Badan Berlebihan10 kajian
- Kanser Paru-paru Bukan Sel Kecil10 kajian
- Leukemia Mieloid Akut8 kajian
- Kanser Paru-paru8 kajian
- Kanser Kolorektal8 kajian
- Kanser Payudara7 kajian
- Kanser Pundi Kencing6 kajian
- Leukemia Limfositik Kronik5 kajian
- Kanser Prostat5 kajian
- COPD5 kajian
- Kegagalan Jantung5 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.